Positive Oct -3/4 and D2–40 Immunohistochemical Expression in Germ Cells and Suspected Histology Pattern of Intratubular Germ Cell Neoplasia in Boys with Cryptorchidism Vanish after the Age of 2 Years

Abstract Introduction Intratubular germ cell neoplasia (ITGCN) is a precursor to testicular germ cell cancer. Adult germ cell cancer immunohistochemical markers may fail to detect ITGCN in prepubertal boys with congenital cryptorchidism, because positive immunohistochemistry is commonly seen in boys younger than the age of 2 years, where most orchiopexies are performed. The aim of the study was to evaluate the diagnostic challenge to differentiate between a histological pattern of ITGCN and a histological pattern with some atypical germ cells and all positive cancer immunohistochemical markers, but no increased risk of malignancy. Materials and Methods Histology sections from 373 testicular biopsies from 289 boys aged 1 month to 2 years operated for cryptorchidism were incubated with primary antibodies including anti-placental-like-alkaline phosphatase, antiOct-3/4, anti-C-kit, anti-D2–40, and in case of repeat biopsy with anti-stem cell factor (SCF) receptor. Results The prevalence of Oct-3/4 and D2–40-positive staining of germ cells in testicular biopsies were in age groups less than 6 months, 100% and 50%; 6–12 months, 60% and 17%; and 1–2 years, 12% and 4%. A 1 year, 1-month-old boy with Prader–Willi syndrome treated with growth hormone had ITGCN in both cryptorchid testes. In another three bilateral nonsyndromic cases, 8 months, 8 months and 1-year-old, a histological pattern in accordance with ITGCN was found. These three boys had a repeat biopsy from both testes performed at the age of 3 years, 4 months, 3.5 years, and 3 years, 10months, respectively. In all cases, the Oct-3/4 and D2–40 positive germ cells turned negative and the histological pattern normalized completely. The primary biopsies had SCF negative germ cells. Conclusion This study is valuable in identifying the age-related change in Oct-3/4 or D2–40 immunopositive germ cells in seminiferous tubules. An ITGCN-like histological pattern in nonsyndromic cryptorchidism will vanish after the age of 3 years. Even when immunohistochemistry is applied, prepubertal ITGCN is so rarely demonstrated in cryptorchid testes, that it is not plausible that ITGCN generally originates during fetal development in cryptorchidism.

[1]  J. Thorup,et al.  The value of positive Oct3/4 and D2-40 immunohistochemical expression in prediction of germ cell neoplasia in prepubertal boys with cryptorchidism , 2016, Scandinavian journal of urology.

[2]  N. Hanna,et al.  Testicular cancer--discoveries and updates. , 2014, The New England journal of medicine.

[3]  Andrew C. Peterson,et al.  Evaluation and treatment of cryptorchidism: AUA guideline. , 2014, The Journal of urology.

[4]  J. Thorup,et al.  Adult immunohistochemical markers fail to detect intratubular germ cell neoplasia in prepubertal boys with cryptorchidism. , 2014, The Journal of urology.

[5]  N. Skakkebæk,et al.  Epigenetic features of testicular germ cell tumours in relation to epigenetic characteristics of foetal germ cells. , 2013, The International journal of developmental biology.

[6]  Ruili Li,et al.  Germ cell development in the postnatal testis: the key to prevent malignancy in cryptorchidism? , 2013, Front. Endocrin..

[7]  J. Thorup,et al.  The relation between adult dark spermatogonia and other parameters of fertility potential in cryptorchid testes. , 2012, The Journal of urology.

[8]  L. Looijenga,et al.  Delayed Recognition of Disorders of Sex Development (DSD): A Missed Opportunity for Early Diagnosis of Malignant Germ Cell Tumors , 2012, International journal of endocrinology.

[9]  L. Looijenga,et al.  Gonadal Pathology and Tumor Risk in Relation to Clinical Characteristics in Patients with 45,X/46,Xy Mosaicism , 2010 .

[10]  C. Bokemeyer,et al.  Stem cell factor as a novel diagnostic marker for early malignant germ cells , 2008, The Journal of pathology.

[11]  L. Richiardi,et al.  Age at surgery for undescended testis and risk of testicular cancer. , 2007, The New England journal of medicine.

[12]  J. Toppari,et al.  Nordic consensus on treatment of undescended testes , 2007, Acta paediatrica.

[13]  H. Leffers,et al.  Identity of M2A (D2-40) antigen and gp36 (Aggrus, T1A-2, podoplanin) in human developing testis, testicular carcinoma in situ and germ-cell tumours , 2006, Virchows Archiv.

[14]  E. R. Meyts Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects , 2006 .

[15]  C. Bokemeyer,et al.  Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells , 2004, The Journal of pathology.

[16]  F. Hadžiselimović,et al.  A diminished postnatal surge of Ad spermatogonia in cryptorchid infants is additional evidence for hypogonadotropic hypogonadism. , 2004, Swiss medical weekly.

[17]  J. Kononen,et al.  POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. , 2003, Cancer research.

[18]  R. Ivell,et al.  The molecular basis of cryptorchidism. , 2003, Molecular human reproduction.

[19]  J. Thorup,et al.  Cryptorchidism: aspects of fertility and neoplasms. A study including data of 1,335 consecutive boys who underwent testicular biopsy simultaneously with surgery for cryptorchidism. , 2001, Hormone research.

[20]  M. Goldstein,et al.  Restoration of spermatogenesis after scrotal replacement of experimentally cryptorchid rat testis: assessment of germ cell apoptosis and eNOS expression , 1999 .

[21]  B. Setchell,et al.  The Parkes Lecture. Heat and the testis. , 1998, Journal of reproduction and fertility.

[22]  D. Cortes Cryptorchidism--aspects of pathogenesis, histology and treatment. , 1998, Scandinavian journal of urology and nephrology. Supplementum.

[23]  A. Sasco,et al.  An excess of testicular germ cell tumors in down's syndrome , 1997, Cancer.

[24]  R. Giller,et al.  The prepubertal testis (prenatal and postnatal): its relationship to intratubular germ cell neoplasia: a combined Pediatric Oncology Group and Children's Cancer Study Group. , 1997, Human pathology.

[25]  N. Skakkebaek,et al.  Prevalence of carcinoma in situ and other histopathological abnormalities in testes of men with a history of cryptorchidism. , 1989, The Journal of urology.

[26]  F. Hadžiselimović,et al.  The significance of postnatal gonadotropin surge for testicular development in normal and cryptorchid testes. , 1986, The Journal of urology.